COMMUNIQUÉS West-GlobeNewswire

Genmab Announces Decision in Arbitration Appeal under License Agreement with Janssen
23/01/2024
Company Announcement COPENHAGEN, Denmark; January 23, 2024 – Genmab A/S (Nasdaq: GMAB) announced today that the appeal arbitrator in its second arbitration arising under its license agreement with Janssen Biotech, Inc [...]
Terranueva annonce le résultat favorable de l’assemblée des créanciers tenue suite au dépôt d’un avis d’intention
23/01/2024
MONTRÉAL, Jan. 22, 2024 (GLOBE NEWSWIRE) -- Terranueva Corporation (CSE: TEQ) (« Terranueva » ou la « Société ») est heureuse d’annoncer que l’assemblée des créanciers tenue aujourd’hui a accepté à 86% la proposition de [...]
Latest Phase III trial data investigating Cabometyx® in combination with immunotherapy to be presented at ASCO GU 2024
22/01/2024
Detailed top-line results from Phase III CONTACT-02 trial demonstrated statistically significant progression-free survival benefit for combination of Cabometyx ® and atezolizumab in metastatic castration-resistant [...]
Ipsen présente les dernières données d'un essai de Phase III évaluant Cabometyx® en association avec une immunothérapie à l'occasion de l'édition 2024 de l'ASCO sur les cancers génito-urinaires
22/01/2024
Les premiers résultats détaillés de l'essai de Phase III CONTACT-02 ont démontré un bénéfice statistiquement significatif en matière de survie sans progression pour Cabometyx ® en association avec l'atézolizumab dans le [...]
PDS Biotech Announces Retirement of Lauren V. Wood, M.D., and Appointment of Kirk V. Shepard, M.D., as Chief Medical Officer
22/01/2024
Board-certified oncologist and hematologist brings over 30 years of medical affairs, clinical operations leadership and commercialization experience to the Company PRINCETON, N.J., Jan. 22, 2024 (GLOBE NEWSWIRE) -- PDS [...]
TransCode Therapeutics Announces Closing of $7.25 Million Public Offering
22/01/2024
BOSTON, Jan. 22, 2024 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ) (the “Company”), an RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today announced the [...]
Evaxion Announces Completion of ADS Ratio Change
22/01/2024
COPENHAGEN, Denmark, Jan. 22, 2024 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, today [...]
ClearPoint Neuro Announces First EU MDR Certification Success and Approval to Ship Product to Europe
22/01/2024
SOLANA BEACH, Calif., Jan. 22, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine [...]
ClearPoint Neuro annonce être arrivé pour la première fois au terme du processus de certification de conformité au Règlement européen MDR et obtenu l’autorisation d’expédier son produit en Europe
22/01/2024
SOLANA BEACH, Californie, 22 janv. 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq : CLPT (la « Société »), une entreprise internationale spécialisée dans les dispositifs médicaux, les thérapies cellulaires et [...]
Option Care Health to Announce Fourth Quarter and Full Year 2023 Financial Results and Host Conference Call
22/01/2024
BANNOCKBURN, Ill., Jan. 22, 2024 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent provider of home and alternate site infusion services, today announced [...]
Oxurion Announces New Strategic Orientation to De-risk and Diversify
22/01/2024
Leuven, BELGIUM, 22 January 2024 9:00 PM CET – Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, announced today its new corporate strategy to further diversify its activities by [...]
ONWARD® to Participate in Basel Healthtech Conference 2024
22/01/2024
CEO Dave Marver will discuss the Company’s leadership in health technology, including spinal cord stimulation with brain-computer interfaces EINDHOVEN, the Netherlands, Jan. 22, 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N [...]
Remsleep Holdings Inc.'s DeltaWave Mask has received questions from FDA regarding 510k submission (K233415)
22/01/2024
TAMPA, Fla., Jan. 22, 2024 (GLOBE NEWSWIRE) -- RemSleep Holdings Inc. (OTCQB: RMSL), a medical device manufacturer dedicated to forever changing the level of treatment provided to Obstructive Sleep Apnea (OSA) has [...]
Rahal Automotive Group Donates $35,000 to SoldierStrong to Help Military Veterans Take Their Next Steps Forward
22/01/2024
HARRISBURG, Pa., Jan. 22, 2024 (GLOBE NEWSWIRE) -- The Bobby Rahal Automotive Group today announced a $35,000 donation to SoldierStrong, a national nonprofit organization with a mission to deliver revolutionary medical [...]
SS Innovations Launches Groundbreaking Inaugural Multi-Specialty Robotic Surgical Conference
22/01/2024
SMRSC 2024 brings global medical experts and technological innovators together to explore the future of robotic surgery 13 Live, broadcasted surgeries were performed by distinguished multi-specialty surgeons, using the [...]
Nusano Names Rohan Jain as Commercial General Manager
22/01/2024
VALENCIA, Calif., Jan. 22, 2024 (GLOBE NEWSWIRE) -- Nusano, a physics company transforming the production of medical radioisotopes, today announced Rohan Jain as its Commercial General Manager. Jain and his team will [...]
Virios Therapeutics Announces Plans to Advance Development of IMC-2 as Treatment for Symptoms Associated with Long-COVID
22/01/2024
- Placebo-Controlled Clinical Proof of Concept Data Expected in Mid-2024 - - Targeting Initiation of IMC-2 Phase 2 program in 2H 2024 - ATLANTA, Jan. 22, 2024 (GLOBE NEWSWIRE) -- Virios Therapeutics, Inc. (Nasdaq: VIRI [...]
AIM ImmunoTech Announces that the First Subject is Enrolled in the Phase 1b/2 Study Evaluating Ampligen® in Combination with AstraZeneca’s Imfinzi® for the Treatment of Late-Stage Pancreatic Cancer
22/01/2024
First enrollment takes place at Erasmus Medical Center in Rotterdam, Netherlands OCALA, Fla., Jan. 22, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that the [...]
Pressure BioSciences Announces Closing of Uncle Bud’s Acquisition in All-Stock Transaction, Completing UltraShear Nanoemulsions Forward Integration with World Class Marketing & Sales
22/01/2024
Merged Companies Will Introduce Revolutionary New Product Capabilities Across Multiple Major Market Sectors, Expecting 2024 Revenues of Over $10 Million, Then Accelerating in Future Years SOUTH EASTON, Mass., Jan. 22, [...]

Pages